These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 38720383

  • 21. Efficacy of a 6-month versus 9-month intermittent treatment regimen in HIV-infected patients with tuberculosis: a randomized clinical trial.
    Swaminathan S, Narendran G, Venkatesan P, Iliayas S, Santhanakrishnan R, Menon PA, Padmapriyadarsini C, Ramachandran R, Chinnaiyan P, Suhadev M, Sakthivel R, Narayanan PR.
    Am J Respir Crit Care Med; 2010 Apr 01; 181(7):743-51. PubMed ID: 19965813
    [Abstract] [Full Text] [Related]

  • 22. Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial.
    Grinsztejn B, De Castro N, Arnold V, Veloso VG, Morgado M, Pilotto JH, Brites C, Madruga JV, Barcellos NT, Santos BR, Vorsatz C, Fagard C, Santini-Oliveira M, Patey O, Delaugerre C, Chêne G, Molina JM, ANRS 12 180 Reflate TB study group.
    Lancet Infect Dis; 2014 Jun 01; 14(6):459-67. PubMed ID: 24726095
    [Abstract] [Full Text] [Related]

  • 23. Delayed diagnosis and treatment of tuberculosis in HIV+ patients in Mozambique: A cost-effectiveness analysis of screening protocols based on four symptom screening, smear microscopy, urine LAM test and Xpert MTB/RIF.
    Orlando S, Triulzi I, Ciccacci F, Palla I, Palombi L, Marazzi MC, Giuliano M, Floridia M, Mancinelli S, Mutemba E, Turchetti G.
    PLoS One; 2018 Jun 01; 13(7):e0200523. PubMed ID: 30024890
    [Abstract] [Full Text] [Related]

  • 24. Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial.
    Lee M, Mok J, Kim DK, Shim TS, Koh WJ, Jeon D, Lee T, Lee SH, Kim JS, Park JS, Lee JY, Kim SY, Lee JH, Jo KW, Jhun BW, Kang YA, Ahn JH, Kim CK, Shin S, Song T, Shin SJ, Kim YR, Ahn H, Hahn S, Won HJ, Jang JY, Cho SN, Yim JJ.
    Trials; 2019 Jan 16; 20(1):57. PubMed ID: 30651149
    [Abstract] [Full Text] [Related]

  • 25. Cost-effectiveness of urine-based tuberculosis screening in hospitalised patients with HIV in Africa: a microsimulation modelling study.
    Reddy KP, Gupta-Wright A, Fielding KL, Costantini S, Zheng A, Corbett EL, Yu L, van Oosterhout JJ, Resch SC, Wilson DP, Horsburgh CR, Wood R, Alufandika-Moyo M, Peters JA, Freedberg KA, Lawn SD, Walensky RP.
    Lancet Glob Health; 2019 Feb 16; 7(2):e200-e208. PubMed ID: 30683239
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Systematic or Test-Guided Treatment for Tuberculosis in HIV-Infected Adults.
    Blanc FX, Badje AD, Bonnet M, Gabillard D, Messou E, Muzoora C, Samreth S, Nguyen BD, Borand L, Domergue A, Rapoud D, Natukunda N, Thai S, Juchet S, Eholié SP, Lawn SD, Domoua SK, Anglaret X, Laureillard D, STATIS ANRS 12290 Trial Team.
    N Engl J Med; 2020 Jun 18; 382(25):2397-2410. PubMed ID: 32558469
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Diagnosis of opportunistic infections: HIV co-infections - tuberculosis.
    Scott L, da Silva P, Boehme CC, Stevens W, Gilpin CM.
    Curr Opin HIV AIDS; 2017 Mar 18; 12(2):129-138. PubMed ID: 28059955
    [Abstract] [Full Text] [Related]

  • 30. Comparative evaluation of intensified short course regimen and standard regimen for adults TB meningitis: a protocol for an open label, multi-center, parallel arms, randomized controlled superiority trial (INSHORT trial).
    Inbaraj LR, Manesh A, Ponnuraja C, Bhaskar A, Srinivasalu VA, Daniel BD.
    Trials; 2024 May 02; 25(1):294. PubMed ID: 38693583
    [Abstract] [Full Text] [Related]

  • 31. Susceptibility to levofloxacin of Myocobacterium tuberculosis isolates from patients with HIV-related tuberculosis and characterization of a strain with levofloxacin monoresistance. Community Programs for Clinical Research on AIDS 019 and the AIDS Clinical Trials Group 222 Protocol Team.
    Perlman DC, El Sadr WM, Heifets LB, Nelson ET, Matts JP, Chirgwin K, Salomon N, Telzak EE, Klein O, Kreiswirth BN, Musser JM, Hafner R.
    AIDS; 1997 Oct 02; 11(12):1473-8. PubMed ID: 9342069
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Management of individuals requiring antiretroviral therapy and TB treatment.
    Cohen K, Meintjes G.
    Curr Opin HIV AIDS; 2010 Jan 02; 5(1):61-9. PubMed ID: 20046149
    [Abstract] [Full Text] [Related]

  • 35. Tuberculosis in Hospitalized Patients With Human Immunodeficiency Virus: Clinical Characteristics, Mortality, and Implications From the Rapid Urine-based Screening for Tuberculosis to Reduce AIDS Related Mortality in Hospitalized Patients in Africa.
    Gupta-Wright A, Fielding K, Wilson D, van Oosterhout JJ, Grint D, Mwandumba HC, Alufandika-Moyo M, Peters JA, Chiume L, Lawn SD, Corbett EL.
    Clin Infect Dis; 2020 Dec 17; 71(10):2618-2626. PubMed ID: 31781758
    [Abstract] [Full Text] [Related]

  • 36. Prednisone for the Prevention of Paradoxical Tuberculosis-Associated IRIS.
    Meintjes G, Stek C, Blumenthal L, Thienemann F, Schutz C, Buyze J, Ravinetto R, van Loen H, Nair A, Jackson A, Colebunders R, Maartens G, Wilkinson RJ, Lynen L, PredART Trial Team.
    N Engl J Med; 2018 Nov 15; 379(20):1915-1925. PubMed ID: 30428290
    [Abstract] [Full Text] [Related]

  • 37. Tuberculosis treatment outcomes among people living with HIV diagnosed using Xpert MTB/RIF versus sputum-smear microscopy in Botswana: a stepped-wedge cluster randomised trial.
    Agizew T, Chihota V, Nyirenda S, Tedla Z, Auld AF, Mathebula U, Mathoma A, Boyd R, Date A, Pals SL, Lekone P, Finlay A.
    BMC Infect Dis; 2019 Dec 16; 19(1):1058. PubMed ID: 31842773
    [Abstract] [Full Text] [Related]

  • 38. Algorithm-guided empirical tuberculosis treatment for people with advanced HIV (TB Fast Track): an open-label, cluster-randomised trial.
    Grant AD, Charalambous S, Tlali M, Karat AS, Dorman SE, Hoffmann CJ, Johnson S, Vassall A, Churchyard GJ, Fielding KL.
    Lancet HIV; 2020 Jan 16; 7(1):e27-e37. PubMed ID: 31727580
    [Abstract] [Full Text] [Related]

  • 39. Electronic pillbox-enabled self-administered therapy versus standard directly observed therapy for tuberculosis medication adherence and treatment outcomes in Ethiopia (SELFTB): protocol for a multicenter randomized controlled trial.
    Manyazewal T, Woldeamanuel Y, Holland DP, Fekadu A, Blumberg HM, Marconi VC.
    Trials; 2020 May 05; 21(1):383. PubMed ID: 32370774
    [Abstract] [Full Text] [Related]

  • 40. Xpert MTB/RIF and Xpert Ultra assays for screening for pulmonary tuberculosis and rifampicin resistance in adults, irrespective of signs or symptoms.
    Shapiro AE, Ross JM, Yao M, Schiller I, Kohli M, Dendukuri N, Steingart KR, Horne DJ.
    Cochrane Database Syst Rev; 2021 Mar 23; 3(3):CD013694. PubMed ID: 33755189
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.